NCT07760051

Brief Summary

The goal of this clinical trial is to evaluate whether AI-assisted workflows improve physicians' admission diagnosis and management planning performance on standardized simulated inpatient cases, among practicing internal medicine and surgery physicians across all seniority levels and across three tiers of the Chinese healthcare system. The main questions it aims to answer are:

  • Does the Agent-assisted workflow yield better structured admission diagnosis and management planning scores than standalone LLM assistance?
  • Does the Agent-assisted workflow outperform the traditional workflow without AI tools? Researchers will compare three parallel groups (traditional workflow group, LLM-assisted group, Agent-assisted group) to determine whether the Agent tool can improve diagnostic accuracy and efficiency. The goal of this clinical trial is to evaluate whether AI-assisted workflows improve physicians' admission diagnosis and management planning performance on standardized simulated inpatient cases, among practicing internal medicine and surgery physicians across all seniority levels and across three tiers of the Chinese healthcare system. The main questions it aims to answer are:
  • Does the Agent-assisted workflow yield better diagnosis and management planning scores than the LLM-assisted workflow?
  • Does the Agent-assisted workflow yield better diagnosis and management planning scores than the conventional workflow without AI assistance? Researchers will compare three parallel groups (traditional workflow group, LLM-assisted group, Agent-assisted group) to determine whether the agent tool can improve diagnostic and management planning performance and efficiency. Participants will:
  • Be recruited from 15 hospitals in China and participate remotely under video proctoring
  • Be randomly assigned to one of the three fixed workflows, with randomization stratified by hospital tier, specialty and seniority
  • Work through 6 anonymized simulated HIS admission cases and complete as many as they can.
  • Submit structured answers for each case covering principal diagnosis, secondary diagnoses, differential diagnoses, diagnostic justification, next diagnostic or therapeutic steps, consultation and referral decisions, and diagnostic confidence.
  • Have their operation logs and time consumption recorded automatically by the study platform.
  • Complete a post-session questionnaire after submitting all cases.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
180

participants targeted

Target at P75+ for not_applicable

Timeline
2mo left

Started Sep 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress33%
Sep 2026Dec 2026

First Submitted

Initial submission to the registry

July 29, 2026

Completed
14 days until next milestone

First Posted

Study publicly available on registry

August 12, 2026

Completed
25 days until next milestone

Study Start

First participant enrolled

September 6, 2026

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2026

Last Updated

September 28, 2026

Status Verified

September 1, 2026

Enrollment Period

3 months

First QC Date

July 29, 2026

Last Update Submit

September 23, 2026

Conditions

Keywords

AI agentLarge Language ModelClinical Decision SupportAdmission DiagnosisDiagnostic AccuracyDiagnostic ReasoningRandomized Controlled TrialManagement Planning

Outcome Measures

Primary Outcomes (1)

  • Mean Normalized Structured Score

    Mean of the rescaled case scores (each case rescaled to 100), divided by the number of cases completed; range 0 to 100.

    Within one-hour study

Secondary Outcomes (2)

  • Active Response Time per Case

    Within one-hour study

  • Degree of Adherence to AI-Generated Recommendations

    Within one-hour study

Study Arms (3)

Agent-assisted group

EXPERIMENTAL
Other: Agent-assisted workflow

LLM-assisted group

EXPERIMENTAL
Other: LLM-assisted workflow

Traditional group

ACTIVE COMPARATOR
Other: Traditional Workflow

Interventions

Conventional resources only: the pre-admission clinical record, conventional search engines, permitted conventional non-generative clinical information resources. No AI assistance.

Traditional group

Conventional resources (the pre-admission clinical record, conventional search engines, permitted conventional non-generative clinical information resources) plus an in-system Agent entry that automatically reads the full record and report images, produces a structured summary with source-text tracing, and supports multi-turn Q\&A and one-click editable drafts.

Agent-assisted group

Conventional resources (the pre-admission clinical record, conventional search engines, permitted conventional non-generative clinical information resources) plus an in-system multi-turn AI dialogue entry. The AI does not automatically read the record; participants paste text or send partial screenshots.

LLM-assisted group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Hold a Medical Practitioner Qualification Certificate and/or Medical License, or be a recognized standardized resident physician; able to independently read electronic medical records, laboratory and imaging reports on an HIS.
  • Currently engaged in clinical work in internal medicine or surgery at one of the 15 participating hospitals.
  • Able to complete the case assessment in one continuous hour without breaks.
  • Able to participate remotely under video proctoring, with a stable internet connection and a working camera.
  • Voluntarily agree to participate and sign the informed consent form, including the declaration not to use unauthorized AI tools during the assessment.
  • Have not participated in case drafting, review, rubric development, or any activity that may leak the reference standard.

You may not qualify if:

  • Have previously accessed the official test cases or reference standard of this study.
  • Unable to complete the training module, qualification test, or all experimental tasks.
  • Have conflicts of interest, e.g. participation in developing core algorithms of the tested system.
  • Unwilling to comply with remote proctoring, including keeping the camera on throughout.
  • Judged unsuitable by the investigators.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

2nd Affiliated Hospital, School of Medicine, Zhejiang University

Hangzhou, Zhejiang, 310009, China

RECRUITING

Study Officials

  • Yuan Ding

    Second Affiliated Hospital, Zhejiang University, School of Medicine

    STUDY CHAIR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Participants and investigators cannot be masked, as the intervention is the workflow itself. Outcome assessors scoring the structured answers are blinded to group allocation; submitted answers are anonymized and stripped of workflow-identifying information before scoring.
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Model Details: Three-arm parallel-group design with 1:1:1 allocation. All arms share the same conventional resources (pre-admission clinical record, conventional search engines, permitted conventional non-generative clinical information resources); the arms differ only in the AI entry added on top (none / LLM / Agent). Randomization is stratified by hospital, specialty and seniority.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 29, 2026

First Posted

August 12, 2026

Study Start

September 6, 2026

Primary Completion (Estimated)

December 1, 2026

Study Completion (Estimated)

December 1, 2026

Last Updated

September 28, 2026

Record last verified: 2026-09

Data Sharing

IPD Sharing
Will not share

Locations